Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Mesoblast issues shares to Osiris Therapeutics after FDA approval of Ryoncil Mesoblast Limited, a pioneering biotechnology company listed on the Australian Securities Exchange (ASX:MSB), has announced the issuance of… byPallavi MadhirajuJanuary 7, 2025